SIS
SPRB

Sound Income Strategies’s Spruce Biosciences SPRB Stock Holding History

Sound Income Strategies’s Portfolio SPRB Stock Details SPRB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-200
Closed -$13.9K – 2555
2026
Q1 		$13.9K Hold
200
– – ﹤0.01% 1350
2025
Q4 		$14.7K Buy
+200
New +$21.4K ﹤0.01% 1282

Other funds holding SPRB

ACM
AIGH Capital Management Baltimore, Maryland $1.59B AUM 855.46% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
CG
Carlyle Group Washington, District of Columbia $10B AUM 10.61% 1-Year Est. Return
AAA
Affinity Asset Advisors New York $2.21B AUM 431.26% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
DMKJ
David M. Knott Jr $189M AUM 67.72% 1-Year Est. Return

Sound Income Strategies's SPRB Position: Q2 2026 in Review

Sound Income Strategies sold out of Spruce Biosciences (SPRB) in Q2 2026, closing a stake of 200 shares — an estimated $13.9K sold.

Sound Income Strategies first reported a position in SPRB in Q4 2025 and held it in 2 quarters. The position peaked at $14.7K in Q4 2025. 35 funds tracked by Wall St. Rank hold SPRB as of Q2 2026.

  • Sound Income Strategies reported no remaining Spruce Biosciences position as of Q2 2026 after selling out during the quarter.
  • Sound Income Strategies sold 200 Spruce Biosciences shares in Q2 2026, an estimated $13.9K.
  • Sound Income Strategies first reported a position in Spruce Biosciences in Q4 2025 and held it in 2 quarters.
  • Sound Income Strategies's Spruce Biosciences position peaked at $14.7K in Q4 2025.
  • 35 funds tracked by Wall St. Rank held Spruce Biosciences as of Q2 2026.

Based on Sound Income Strategies's 13F filing for Q2 2026, filed 20 Jul 2026.